Home  /  News  /  Newsroom

The Role of Litigation in Response to the Opioid Epidemic

The Role of Litigation in Response to the Opioid Epidemic

In March, Purdue Pharma agreed to pay $270 million to the state of Oklahoma in the first state settlement of litigation stemming from the opioid epidemic. There are more than 1,600 other cases pending across the United States. As more of these cases head towards possible settlement agreements, public health experts are weighing in on the best use of these funds to respond to the ongoing crisis. Additionally, there may be parallels to the 1998 Tobacco Master Settlement Agreement which continues to provide payments to states.

Please join us May 13 at the Bipartisan Policy Center as we host Oklahoma Attorney General Mike Hunter and an expert panel to discuss these issues. Panelists will discuss the role of litigation settlements in supporting prevention, treatment, and recovery efforts to address the opioid epidemic.

Keynote discussion with:

Mike Hunter
Oklahoma Attorney General

Jason Grumet
President, Bipartisan Policy Center

Panel discussion featuring:

Abbe Gluck
Professor of Law and Faculty Director of the Solomon Center for Health Law and Policy, Yale Law School

Marcia Lee Taylor
Executive Vice President, External and Government Relations, Center on Addiction

Matthew Myers
President, Campaign for Tobacco-Free Kids

Moderated by:

Regina LaBelle
Program Director of the Addiction and Public Policy Initiative, Georgetown University’s O’Neill Institute for National and Global Health Law

For a readout of the transcript, click here: https://www.c-span.org/video/?460645-1/litigation-opioid-manufacturers